期刊文献+

扩张型心肌病患者循环中miR-5196-5p、miR-652-5p表达的改变及其临床意义 被引量:2

Expression changes and clinical significance of miR-5196-5p and miR-652-5p in dilated cardiomyopathy patients
下载PDF
导出
摘要 目的:通过mi RNA Array芯片技术,了解扩张型心肌病(dilated cardiomyopathy,DCM)患者血浆mi RNA表达谱的差异,探索这种差异与左室舒张末内径(left ventricular end-diastolic dimension,LVEDd)、左室射血分数(left ventricular ejectionfraction,LVEF)及N末端脑钠肽前体(N-terminal of the prohormone brain natriuretic peptide,NT-pro BNP)等心衰指标的关系,并预测其作用靶基因。方法:入选南京胸科医院心脏科收住的8例明确诊断的DCM患者,抽提血浆总RNA,采用Agilent Humanmi RNAs Array(V19.0)芯片技术,与4例健康对照进行表达谱的差异筛选,对改变最明显的mi RNA进行30例患者的进一步验证。检测两组受检者生化指标、NT-pro BNP,测量LVEDd、LVEF,并进行变量间的相关分析。Target Scan和mi RBD数据库预测靶基因。结果:与对照组相比,病例组中共发现36个有意义的mi RNAs表达差异,其中25个上调的mi RNA中,mi R-5196-5p上调最明显,下调的mi RNA中,mi R-652-5p下调最明显。该结果在后续30例DCM患者的验证中也得到证实。Pearson线性相关分析显示,mi R-5196-5p上调水平与LVEDd呈正相关,mi R-652-5p水平与LVEDd、NT-pro BNP呈负相关,与LVEF呈正相关。靶基因分别预测到DCM相关基因VCL、RBM20等。结论:DCM患者血浆中mi R-5196-5p表达明显上调,mi R-652-5p表达下调,并与左室功能、心室重构相关。进一步研究有可能揭示mi R-5196-5p、mi R-652-5p在心衰致病中的机制,并有可能成为评估疾病疗效及预后的新指标或潜在治疗靶点。 Objective:The study aimed to investigate differentially expressed microRNAs (miRNAs)and their association with left ventricular end-diastolic dimension (LVEDd), left ventricular ejection fraction (LVEF), N-terminal of the prohormone brain natriuretic peptide (NT-proBNP)in human dilated cardiomyopathy (DCM)by miRNAs array, and to predict their target gene. Methods: The expression levels of plasma miRNAs of 8 DCM patients and 4 healthy controls were detected by using the Agilent human miRNAs array (V19.0), followed by real-time RT-PCR analysis to validate the expression changes of miRNAs. NT-proBNP, LVEDd and LVEF were measured and analyzed using Pearson linear correlation analysis. The prediction analysis for microarrays (PAM)method was used to identify the differentially expressed miRNAs. Results: Thirty-six differentially expressed miRNAs were identified. There were 25 upregulated and 11 downregulated human miRNAs, of which miR-5196-Sp and miR-652-5p were the most significant. Pearson linear correlation analysis showed that miR-5196-5p level was positively correlated with LVEDd, whereas miR-652-Sp was positively correlated with LVEF values and negatively correlated with NT-proBNP and LVEDd. Moreover, correlative genes such as VCL and RBM20 related with DCM were predicted. Conclusion: The screened differentially expressed miRNAs may be involved in the development of DCM. Specific miRNAs, such as miR-5196-Sp and miR-652-5p, may be considered as new targets for the diagnosis and treatment of human DCM.
作者 王林林 吴晓馗 李翔宇 黄进 戴剑 Wang Linlin, Wu Xiaokui, Li Xiangyu, Huang Jin, Dai Jian(Department of Cardiology, Nanjing Chest Hospital, Nanjing 210029, China)
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2018年第9期1220-1225,共6页 Journal of Nanjing Medical University(Natural Sciences)
基金 南京市卫生局重点项目(ZKX13040) 南京市卫生局一般项目(YKK17187)
关键词 扩张型心肌病 微阵列分析 miRNA 靶基因 dilated cardiomyopathy microarray analysis microRNA target gene
  • 相关文献

参考文献1

二级参考文献230

  • 1David P Bartel.MicroRNAs[J]. Cell . 2004 (2)
  • 2Eva van Rooij.The Art of MicroRNA Research[J]. Circulation Research . 2011 (2)
  • 3Huating Wang,Ramiro Garzon,Hao Sun,Katherine J. Ladner,Ravi Singh,Jason Dahlman,Alfred Cheng,Brett M. Hall,Stephen J. Qualman,Dawn S. Chandler,Carlo M. Croce,Denis C. Guttridge.NF-κB–YY1–miR-29 Regulatory Circuitry in Skeletal Myogenesis and Rhabdomyosarcoma[J]. Cancer Cell . 2008 (5)
  • 4Donald Lloyd-Jones,Robert Adams,Mercedes Carnethon,Giovanni De Simone,T Bruce Ferguson,Katherine Flegal,Earl Ford,Karen Furie,Alan Go,Kurt Greenlund,Nancy Haase,Susan Hailpern,Michael Ho,Virginia Howard,Brett Kissela,Steven Kittner,Daniel Lackland,Lynda Lisabeth,Ariane Marelli,Mary McDermott,James Meigs,Dariush Mozaffarian,Graham Nichol,Christopher O?Donnell,Veronique Roger,Wayne Rosamond,Ralph Sacco,Paul Sorlie,Randall Stafford,Julia Steinberger,Thomas Thom,Sylvia Wasserthiel-Smoller,Nathan Wong,Judith Wylie-Rosett,Yuling Hong.Heart Disease and Stroke Statistics—2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee[J]. Circulation . 2009 (3)
  • 5Vijay Divakaran,Douglas L. Mann.The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure[J]. Circulation Research . 2008 (10)
  • 6Eva van Rooij,William S. Marshall,Eric N. Olson.Toward MicroRNA-Based Therapeutics for Heart Disease: The Sense in Antisense[J]. Circulation Research . 2008 (9)
  • 7David W. Salzman,Joanne B. Weidhaas.SNPing cancer in the bud: MicroRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer[J].Pharmacology and Therapeutics.2012
  • 8Joshua T. Mendell,Eric N. Olson.MicroRNAs in Stress Signaling and Human Disease[J]. Cell . 2012 (6)
  • 9Yunhui Cheng,Ruirui Ji,Junming Yue,Jian Yang,Xiaojun Liu,He Chen,David B. Dean,Chunxiang Zhang.MicroRNAs Are Aberrantly Expressed in Hypertrophic Heart[J]. The American Journal of Pathology . 2007 (6)
  • 10Haihai Liang,Chun Zhang,Tao Ban,Yu Liu,Liu Mei,Xianmei Piao,Dan Zhao,Yanjie Lu,Wenfeng Chu,Baofeng Yang.A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis[J]. International Journal of Biochemistry and Cell Biology . 2012 (12)

共引文献10

同被引文献7

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部